Sinovac Biotech (SVA) Income from Continuing Operations (2009 - 2020)
Sinovac Biotech (SVA) posted Income from Continuing Operations of -$326.15 million for FY2025, compared with $94.02 million in FY2024.
Analysis
Sinovac Biotech (SVA) Income from Continuing Operations (2009 - 2020) Analysis & Trends
Since FY2009, Sinovac Biotech has reported Income from Continuing Operations for 17 years.
- The FY2025 figure stands as the lowest annual Income from Continuing Operations since FY2022.
- Business Quant data shows SVA's Income from Continuing Operations at $94.02 million in FY2024 (+90.0%), $49.49 million in FY2023, -$1.1 billion in FY2022 and $14.65 billion in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 197.40 Mn |
| Sep 30, 2020 | 32.82 Mn |
| Jun 30, 2020 | 1.07 Mn |
| Mar 31, 2020 | -9.52 Mn |
| Dec 31, 2019 | 39.29 Mn |
| Sep 30, 2019 | 2.64 Mn |
| Jun 30, 2019 | 12.25 Mn |
| Mar 31, 2019 | 8.22 Mn |
| Dec 31, 2018 | 573,000.00 |
| Sep 30, 2018 | 7.40 Mn |
| Jun 30, 2018 | 453,000.00 |
| Mar 31, 2018 | 16.69 Mn |
| Dec 31, 2016 | 7.53 Mn |
| Sep 30, 2016 | 4.28 Mn |
| Jun 30, 2016 | -12.56 Mn |
| Mar 31, 2016 | -1.59 Mn |
| Dec 31, 2015 | 496,000.00 |
| Sep 30, 2015 | -1.80 Mn |
| Jun 30, 2015 | 3.70 Mn |
| Mar 31, 2015 | -2.65 Mn |
API Access
Sinovac Biotech Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();